Electromedical Technologies (Electromedical Technologies) GF Value : $0.01 (As of May. 11, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-11), Electromedical Technologies's share price is $0.0005. Electromedical Technologies's GF Value is $0.01. Therefore, Electromedical Technologies's Price-to-GF-Value for today is 0.05.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Electromedical Technologies is Possible Value Trap, Think Twice.

Electromedical Technologies (OTCPK:EMED) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Electromedical Technologies's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.0005	/	0.01
	=	0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromedical Technologies GF Value Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Electromedical Technologies (Electromedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260

Website

https://www.electromedtech.com

Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.

Executives

Hymers Iii R. Leslie	director	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson	director	PO BOX 41828, MESA AZ 41828
Donald J Steinberg	10 percent owner	3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson	director, officer: CEO, CFO	16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260